A detailed history of Synovus Financial Corp transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Synovus Financial Corp holds 95,504 shares of RCKT stock, worth $1.42 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
95,504
Previous 168,090 43.18%
Holding current value
$1.42 Million
Previous $3.62 Million 51.27%
% of portfolio
0.02%
Previous 0.05%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$17.6 - $25.88 $1.28 Million - $1.88 Million
-72,586 Reduced 43.18%
95,504 $1.76 Million
Q2 2024

Aug 13, 2024

BUY
$20.66 - $26.72 $1.75 Million - $2.26 Million
84,679 Added 101.52%
168,090 $3.62 Million
Q1 2024

May 14, 2024

SELL
$26.16 - $30.74 $33,223 - $39,039
-1,270 Reduced 1.5%
83,411 $2.25 Million
Q3 2023

Nov 13, 2023

BUY
$15.07 - $24.05 $55,743 - $88,960
3,699 Added 4.57%
84,681 $1.74 Million
Q2 2023

Aug 08, 2023

SELL
$16.59 - $23.6 $89,785 - $127,723
-5,412 Reduced 6.26%
80,982 $1.61 Million
Q1 2023

May 11, 2023

SELL
$15.79 - $22.6 $671,390 - $960,952
-42,520 Reduced 32.98%
86,394 $1.48 Million
Q4 2022

Feb 06, 2023

BUY
$15.5 - $22.76 $645,745 - $948,204
41,661 Added 47.75%
128,914 $2.52 Million
Q3 2022

Oct 27, 2022

SELL
$12.37 - $18.41 $5,046 - $7,511
-408 Reduced 0.47%
87,253 $1.4 Million
Q2 2022

Aug 10, 2022

BUY
$7.96 - $16.64 $43,183 - $90,272
5,425 Added 6.6%
87,661 $1.21 Million
Q1 2022

May 12, 2022

BUY
$13.16 - $23.68 $245,605 - $441,939
18,663 Added 29.36%
82,236 $1.31 Million
Q4 2021

Feb 14, 2022

BUY
$21.52 - $36.02 $314,428 - $526,288
14,611 Added 29.84%
63,573 $1.38 Million
Q3 2021

Nov 08, 2021

BUY
$27.42 - $48.97 $187,114 - $334,171
6,824 Added 16.19%
48,962 $1.46 Million
Q2 2021

Aug 11, 2021

BUY
$39.41 - $47.25 $419,243 - $502,645
10,638 Added 33.77%
42,138 $1.87 Million
Q1 2021

May 11, 2021

SELL
$43.34 - $65.91 $718,230 - $1.09 Million
-16,572 Reduced 34.47%
31,500 $1.4 Million
Q4 2020

Feb 11, 2021

SELL
$23.3 - $59.57 $193,692 - $495,205
-8,313 Reduced 14.74%
48,072 $2.64 Million
Q3 2020

Nov 09, 2020

BUY
$20.5 - $28.59 $99,240 - $138,404
4,841 Added 9.39%
56,385 $1.29 Million
Q2 2020

Aug 10, 2020

SELL
$13.32 - $22.61 $341,444 - $579,584
-25,634 Reduced 33.21%
51,544 $1.08 Million
Q1 2020

Apr 24, 2020

BUY
$9.71 - $25.11 $433,823 - $1.12 Million
44,678 Added 137.47%
77,178 $1.08 Million
Q4 2019

Feb 06, 2020

BUY
$11.07 - $24.23 $359,775 - $787,475
32,500 New
32,500 $740,000

Others Institutions Holding RCKT

About ROCKET PHARMACEUTICALS, INC.


  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $1.12B
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track Synovus Financial Corp Portfolio

Follow Synovus Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Synovus Financial Corp with notifications on news.